SCHEMBL30615364

SCHEMBL30615364

Nc1cccc(-c2ccnc(Br)c2)c1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.39
▸ MAP4K4 O95819 1/20 0.38
▸ MAPK10 P53779 1/20 0.36
▸ ACE2 Q9BYF1 1/20 0.33
▸ DYRK1A Q13627 3/20 0.33
▸ ALOX5AP P20292 2/20 0.32
▸ ATAD2 Q6PL18 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ CD44 P16070 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ IMPDH2 P12268 1/20 0.31
▸ HKDC1 Q2TB90 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ FYN P06241 1/20 0.31
▸ FEN1 P39748 1/20 0.31
▸ DHFR P00374 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28488492 1.00 IDO1 (0.39) IDO1MAP4K4MAPK10ACE2DYRK1A
SCHEMBL21463384 0.79 TDO2 (0.46) MAP4K4DYRK1ACD44GSK3B
SCHEMBL21463603 0.75 FEN1 (0.33) IDO1MAP4K4ALOX5APALDH1A1CD44
SCHEMBL30615396 0.75 FEN1 (0.33) IDO1MAP4K4ALOX5APALDH1A1CD44
SCHEMBL15364728 0.74 IMPDH2 (0.51) ACE2ATAD2ALDH1A1CD44HSD17B10
SCHEMBL28823621 0.73 MAP4K4 (0.36) MAP4K4MAPK10ALOX5APFYNFEN1
SCHEMBL31504094 0.73 IDO1 (0.42) IDO1MAP4K4HKDC1KDM4EMEN1
SCHEMBL23090584 0.72 TGFBR1 (0.47) MAP4K4DYRK1AALOX5APFEN1DHFR
SCHEMBL17427069 0.72 NISCH (0.42) IDO1ALDH1A1HSD17B10GSK3BKDM4E
SCHEMBL22912663 0.72 IDO1 (0.55) IDO1MAPK10DYRK1AALOX5APALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 — — CN disclosed
Send feedback